Arcutis Biotherapeutics, Inc. ARQT Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $43.22M-39.9% | $71.95M-19.4% | $89.32M+62.8% | $54.88M-44.0% | ||
| $178.08M+13.7% | $156.62M-14.6% | $183.46M-48.5% | $355.95M+22.5% | ||
| $453.45M+112% | $213.75M+184% | $75.2M+591% | $10.89M— | ||
| $77.99M+40.1% | $55.67M+20.8% | $46.07M+108% | $22.11M— | ||
| $411.23M+22.5% | $335.82M+1.6% | $330.43M-24.5% | $437.41M+8.6% | ||
| $1.04M+0.2% | $1.04M-32.4% | $1.54M-18.2% | $1.88M-16.8% | ||
| $14.81M+56.3% | $9.48M+47.2% | $6.44M-10.4% | $7.19M— | ||
| $432.97M+24.1% | $348.89M+2.2% | $341.37M-24.0% | $449.27M+10.1% | ||
| $57.93M+6.4% | $54.46M-0.6% | $54.81M+42.8% | $38.4M+113% | ||
| $1M— | $0— | $0— | —— | ||
| $129.84M+60.3% | $81.01M+73.6% | $46.67M+23.4% | $37.81M+13.4% | ||
| $107.96M+0.7% | $107.2M-46.9% | $201.8M+2.0% | $197.77M+173% | ||
| $243.49M+27.3% | $191.35M-24.3% | $252.7M+5.4% | $239.69M+117% | ||
| 300M+2,499,900% | 12K+33.3% | 9K+50.0% | 6K+20.0% | ||
| -$1.14B-1.4% | -$1.12B-14.3% | -$981.9M-36.4% | -$719.76M-76.3% | ||
| $189.48M+20.3% | $157.54M+77.7% | $88.67M-57.7% | $209.58M-29.6% | ||
| $432.97M+24.1% | $348.89M+2.2% | $341.37M-24.0% | $449.27M+10.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Arcutis Biotherapeutics, Inc.'s total assets?
- Arcutis Biotherapeutics, Inc. (ARQT) holds $460.0M in total assets, up 33.7% year over year.
- How much debt does Arcutis Biotherapeutics, Inc. have?
- Arcutis Biotherapeutics, Inc. carries $114.7M in total debt against $189.6M of shareholders' equity, a debt-to-equity ratio of 0.60.
- How much cash does Arcutis Biotherapeutics, Inc. have?
- Arcutis Biotherapeutics, Inc. holds $35.1M in cash and equivalents.
- Can Arcutis Biotherapeutics, Inc. cover its short-term obligations?
- Its current ratio is 2.68 — current assets exceed current liabilities.
- Where does Arcutis Biotherapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from Arcutis Biotherapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
